Advancing NICU Diagnosis: Genome Sequencing Delivers Clinical and Economic Benefits
Among the most important benefits of genomic sequencing technologies is their potential to speed the diagnosis of critically ill infants suspected to have a genetic disorder. Studies such as the Genomic Medicine in Ill Infants and Newborns (GEMINI) Study, co-led by Tufts CTSI Associate Director Jonathan Davis, MD, show that clinical genomics can have high … Continued